Please use this identifier to cite or link to this item:
http://ir.futminna.edu.ng:8080/jspui/handle/123456789/16408
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Busari, M.B | - |
dc.contributor.author | Muhammad, H.L | - |
dc.contributor.author | Ogbadoyi, E.O | - |
dc.contributor.author | Kabiru, A.Y | - |
dc.contributor.author | Sani, S. | - |
dc.contributor.author | Yusuf, R.S | - |
dc.date.accessioned | 2023-01-01T11:10:31Z | - |
dc.date.available | 2023-01-01T11:10:31Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | Busari et al.,2015 | en_US |
dc.identifier.issn | 2394-1103 | - |
dc.identifier.uri | http://repository.futminna.edu.ng:8080/jspui/handle/123456789/16408 | - |
dc.description | Moringa oleifera Oil antidiabetic | en_US |
dc.description.abstract | Aim: To investigate the antidiabetic properties of seed oil of Moringa oleifera Lam. Extracted with petroleum ether and dichloromethane and compared with glibenclimide. Study Design: Experimental study design was adopted. Methodology: The 2.0 ml/kg body weight (kg.bw) of the oil, 500 μg/kg.bw of glibenclimide and 2.0 ml/kg.bw of DMSO (Diabetic control group) were given orally to rats in their respective groups after induction with 130 mg/kg.bw of alloxan monohydrate. Results: At 21st day, the glibenclimide treated group and oil extract of petroleum ether and | en_US |
dc.description.sponsorship | Self | en_US |
dc.language.iso | en | en_US |
dc.publisher | Journal of Applied Life Sciences International | en_US |
dc.relation.ispartofseries | ;2(4): 160-174. | - |
dc.subject | Moringa oleifera, glibenclimide, antidiabetic, biochemical, diabetes | en_US |
dc.title | In vivo Evaluation of Antidiabetic Properties of Seed Oil of Moringa oleifera Lam. | en_US |
dc.type | Article | en_US |
Appears in Collections: | Biochemistry |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Moringa oil antidiabetic.pdf | 416.54 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.